[go: up one dir, main page]

EA201890212A1 - Новое применение сульфата декстрана - Google Patents

Новое применение сульфата декстрана

Info

Publication number
EA201890212A1
EA201890212A1 EA201890212A EA201890212A EA201890212A1 EA 201890212 A1 EA201890212 A1 EA 201890212A1 EA 201890212 A EA201890212 A EA 201890212A EA 201890212 A EA201890212 A EA 201890212A EA 201890212 A1 EA201890212 A1 EA 201890212A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dextran sulfate
sulfate application
new dextran
new
application
Prior art date
Application number
EA201890212A
Other languages
English (en)
Other versions
EA034313B1 (ru
Inventor
Ларс Брюс
Адам Брюс
Андерс Ваас
Original Assignee
Тх Медик Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тх Медик Аб filed Critical Тх Медик Аб
Publication of EA201890212A1 publication Critical patent/EA201890212A1/ru
Publication of EA034313B1 publication Critical patent/EA034313B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Настоящие варианты осуществления относятся к применению сульфата декстрана, предназначенного для системного введения для лечения, ингибирования или предупреждения фиброза миокарда у субъекта.
EA201890212A 2015-07-30 2016-07-15 Применение сульфата декстрана EA034313B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1551050A SE539575C2 (en) 2015-07-30 2015-07-30 Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis
PCT/SE2016/050720 WO2017018922A1 (en) 2015-07-30 2016-07-15 New use of dextran sulfate

Publications (2)

Publication Number Publication Date
EA201890212A1 true EA201890212A1 (ru) 2018-06-29
EA034313B1 EA034313B1 (ru) 2020-01-28

Family

ID=57884849

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890212A EA034313B1 (ru) 2015-07-30 2016-07-15 Применение сульфата декстрана

Country Status (11)

Country Link
US (1) US10478451B2 (ru)
EP (1) EP3328395B1 (ru)
JP (1) JP6837679B2 (ru)
CN (2) CN107921055A (ru)
BR (1) BR112018001942A2 (ru)
DK (1) DK3328395T3 (ru)
EA (1) EA034313B1 (ru)
ES (1) ES2882115T3 (ru)
HK (1) HK1246640A1 (ru)
SE (1) SE539575C2 (ru)
WO (1) WO2017018922A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3532072T (pt) * 2017-05-17 2020-03-05 Tx Medic Ab Tratamento do glaucoma
WO2018212708A1 (en) * 2017-05-17 2018-11-22 Tx Medic Ab Treatment of glaucoma
CN111263636A (zh) * 2017-09-08 2020-06-09 Tx医生公司 硫酸葡聚糖的新用途
ES2953184T3 (es) * 2018-03-09 2023-11-08 Carmeda Ab Mejoras en procesos de inmovilización de entidades biológicas
SE543275C2 (en) * 2019-03-07 2020-11-10 Tx Medic Ab Treatment efficiency evaluation
SE544447C2 (en) * 2020-09-29 2022-05-31 Tx Medic Ab Treatment of fatty liver diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP2000507204A (ja) 1995-12-18 2000-06-13 ステイヒテイング・サンキン・ブロードボールジーニング Ｃ１―インヒビターの補体及び血液凝固阻害特性の強化
US20040224922A1 (en) 1999-08-26 2004-11-11 Malcolm King Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
SE525461C3 (sv) * 2002-11-28 2005-03-23 Prophymed Ab Ny användning av dextransulfat
WO2007028053A2 (en) * 2005-09-02 2007-03-08 X-Cell Medical Incorporated Methods of treating and preventing cardiac disorders
WO2007075388A2 (en) * 2005-12-15 2007-07-05 X-Cell Medical Incorporated Methods of locally treating and preventing cardiac disorders
US9023831B2 (en) * 2007-04-24 2015-05-05 Novelmed Therapeutics, Inc. Methods and compositions of inhibiting complement and cellular activation with Dextran Sulfate
WO2011091167A2 (en) * 2010-01-22 2011-07-28 The General Hospital Corporation Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases
WO2013057167A1 (en) * 2011-10-18 2013-04-25 Csl Behring Gmbh Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii
CN102973593A (zh) * 2012-11-26 2013-03-20 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗肝纤维化药物中的应用
NZ727008A (en) * 2014-06-12 2020-05-29 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
WO2015190989A1 (en) * 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject

Also Published As

Publication number Publication date
EP3328395B1 (en) 2021-06-09
CN107921055A (zh) 2018-04-17
BR112018001942A2 (pt) 2018-09-18
EA034313B1 (ru) 2020-01-28
EP3328395A4 (en) 2018-06-20
JP2018521086A (ja) 2018-08-02
SE539575C2 (en) 2017-10-17
US20180221403A1 (en) 2018-08-09
CN114712385A (zh) 2022-07-08
SE1551050A1 (en) 2017-01-31
EP3328395A1 (en) 2018-06-06
ES2882115T3 (es) 2021-12-01
WO2017018922A1 (en) 2017-02-02
US10478451B2 (en) 2019-11-19
HK1246640A1 (zh) 2018-09-14
JP6837679B2 (ja) 2021-03-03
DK3328395T3 (da) 2021-08-09

Similar Documents

Publication Publication Date Title
EA201890212A1 (ru) Новое применение сульфата декстрана
MX2017004579A (es) Estructuras fibrosas solubles y metodos para fabricarlas.
HK1252512A1 (zh) 向眼部遞送藥劑的方法
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
UA117008C2 (uk) IN VITRO ТРАНСКРИБОВАНА мРНК ТА КОМПОЗИЦІЯ, ЩО ЇЇ МІСТИТЬ, ДЛЯ ЗАСТОСУВАННЯ В ЛІКУВАННІ МУКОВІСЦИДОЗУ В ССАВЦЯ
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
CL2015002860A1 (es) Antagonistas de la alfa-v-beta-6 integrina
TR201902516T4 (tr) Glukagon-glp-1-gıp üçlü agonist bileşikleri.
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
BR112016006613A2 (pt) métodos para produção, estabilização e uso de blastosporos fúngicos
MX380512B (es) Formulación de revestimiento para madera.
CL2015002897A1 (es) Inhibidores de bace1
MX386055B (es) Uso de medicamentos para disminuir la evolución de la enfermedad de parkinson.
DK3606926T3 (da) Heteroaromatiske forbindelser anvendelige i terapi
AR110404A1 (es) MÉTODOS PARA EL TRATAMIENTO DE ENFERMEDADES FIBRÓTICAS UTILIZANDO EL INTERFERÓN-l
BR112018000217A2 (pt) sistemas de distribuição de nanopartículas aperfeiçoados
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
TWD180565S (zh) 塗抹器
FR3026399B1 (fr) Grue, notamment grue-derrick
MX373177B (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
MX2018011222A (es) Ambrisentan para uso en el tratamiento de insuficiencia renal aguda.
DK3265429T3 (da) Nanopartikler til anvendelse som hæftningscentre i superledere
TWD174242S (zh) 攜帶型洗淨機
EA201690914A1 (ru) Новое соединение для лечения тяжелой гипогликемии
EA201691036A1 (ru) Новое соединение для лечения тяжелой гипогликемии

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM